Doxorubicin: Effect of different schedules on toxicity and anti-tumor efficacy
- 1 May 1989
- journal article
- review article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (5) , 873-882
- https://doi.org/10.1016/0277-5379(89)90135-1
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Protective Effect of the Bispiperazinedione ICRF-187 against Doxorubicin-Induced Cardiac Toxicity in Women with Advanced Breast CancerNew England Journal of Medicine, 1988
- Doxorubicin and Methotrexate on a Weekly Schedule in Patients with SarcomasOncology, 1987
- Weekly Low-Dose Adriamycin in Hormone-Resistant Metastatic Cancer of the ProstateScandinavian Journal of Urology and Nephrology, 1987
- Prospective evaluation of cardiotoxicity during a six-hour doxorubicin infusion regimen in women with adenocarcinoma of the breastThe American Journal of Medicine, 1985
- Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating AgentsNew England Journal of Medicine, 1984
- Mini-dose weekly adriamycin therapy for patients with advanced malignant disease at increased risk for adriamycin toxicityAmerican Journal of Clinical Oncology, 1983
- Prospective randomized study of the role of N-acetyl cysteine in reversing doxorubicin-induced cardiomyopathyAmerican Journal of Clinical Oncology, 1982
- CLINICAL AND PHARMACOLOGIC INVESTIGATION OF THE EFFECTS OF α‐TOCOPHEROL ON ADRIAMYCIN CARDIOTOXICITY*Annals of the New York Academy of Sciences, 1982
- Adriamycin therapy by continuous intravenous infusion in patients with metastatic breast cancerCancer, 1982
- Clinical Evaluation of Adriamycin, a New Antitumour AntibioticBMJ, 1969